|
Webinars | COVID Vaccine Resources | Vaccine Deployment | Vaccine Administration, Handling, and Billing | Patient Information
Breaking News Update - August 23, 2021 - FDA Fully Approves Pfizer COVID-19 Vaccine
The FDA officially granted full approval to Pfizer and BioNTech for their COVID-19 vaccine for use in Americans 16 years of age and older. The vaccine continues to be available under emergency use authorization (EUA) for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals. It will be marketed as Comirnaty.
Breaking News Update - August 18, 2021 - US Health Officials Recommend Third COVID-19 Vaccine Dose
U.S. health officials are recommending all Americans receive a third dose of the COVID-19 vaccine but with a staggered rollout. Currently, certain immunocompromised people (i.e., people who have undergone solid organ transplantation or have been diagnosed with conditions that are considered to have an equivalent level of immunocompromise) are eligible for the third dose and can receive it immediately. All other individuals will be eligible starting September 20. APA is providing door and lobby signs to help inform your patients about these changes.
Breaking News Update - May 12, 2021 - FDA, CDC, and ACIP Authorize Pfizer COVID-19 Vaccine for Use in Adolescents Ages 12-15
FDA, CDC, and ACIP have all authorized the Pfizer COVID-19 vaccine for use in adolescents ages 12-15. While the Pfizer vaccine is now authorized for ages 12 and up, the Moderna and Johnson & Johnson vaccines are currently only authorized for ages 18 and up.
Update - March 30, 2021 - Governor Hutchinson Opens COVID Vaccination to All Arkansans Ages 16+
On Tuesday, March 30, Governor Asa Hutchinson moved Arkansas into Phase 2, making any Arkansan ages 16 and over eligible to receive the COVID-19 vaccine. Note: The Pfizer vaccine is currently the only COVID-19 vaccine approved for ages 16 and over. Moderna and Johnson & Johnson is approved for ages 18 and over.
Webinars
- APA Monoclonal Antibody Therapy Webinar - Tuesday, August 31, 2021
- ADH Monoclonal Antibody Therapy Webinar - Wednesday, July 28, 2021
- APA COVID-19 Vaccine Webinar - Tuesday, May 18, 2021
- APA COVID-19 Vaccine Webinar - Tuesday, May 11, 2021
- APA COVID-19 Vaccine Webinar - Sunday, January 31, 2021
- APA COVID-19 Vaccine Webinar - Sunday, January 17, 2021
- APA COVID-19 Vaccine Webinar - Wednesday, January 13, 2021
- APA COVID-19 Vaccine Webinar - Sunday, January 10, 2021
- APA COVID-19 Vaccine Webinar - Sunday, January 3, 2021
- APA COVID-19 Vaccine Webinar - Tuesday, December 29
- APA COVID-19 Vaccine Webinar - Monday, December 28
- APA COVID-19 Vaccine Webinar - Monday, December 14
- APA COVID-19 Vaccine Webinar - Tuesday, November 24
COVID Vaccine Resources
Vaccine Deployment
Vaccine Administration, Handling, and Billing
- Arkansas Board of Pharmacy Guidance on Vaccine Clinics, Using Techs and Interns to Administer, and Partnering with Other Healthcare Providers
- CDC’s COVID-19 Vaccination Communication Toolkit for Medical Centers, Clinics, and Clinicians
- Interim Clinical Considerations for Use of Pfizer-BioNTech COVID-19 Vaccine
- Product Information Guide for Providers
- Pfizer COVID-19 Standing Orders for Administering Vaccine to Persons 16 Years of Age and Older
- CDC - Coadministration of COVID-19 Vaccine with Other Vaccines
- How to Manage COVID-19 Vaccination Efforts in Patients in Quarantine, Exposed to, or Infected with COVID-19 in Long Term Care Settings or Other Settings
- Triage of Persons Presenting for Pfizer COVID-19 Vaccination
- Provider Universal COVID-19 Patient Consent Form - 2 Pages - Updated August 2021
- Provider Universal COVID-19 Patient Consent Form - Spanish - Updated form coming soon
- COVID-19 Vaccine Inventory Management
- WebIZ Flat File Data Import (Updated March 29)
- PioneerRx Workflow
- Dry Ice Response Guide
- V-Safe Information Sheet
- COVID-19 Vaccine Billing and Reimbursement
- Blue Cross Blue Shield Pharmacist Credentialing for Medical Benefits
- CVS Pharmacy Update - COVID-19 Vaccine Administration Network
- NCPDP Emergency Preparedness Guidance - COVID-19 Vaccines (information on vaccine billing)
- CDC’s COVID-19 Vaccination Communication Toolkit for Medical Centers, Clinics, and Clinicians
- COVID-19 Test Results Online Reporting Tool - The Arkansas Department of Health has launched a new online reporting tool for all COVID-19 testing. The online form allows for reporting of a single patient or multiple patients and is preferable compared to faxing results to allow for accurate information available for immediate use and contact tracing. It is critical to report results as quickly and accurately as possible so that patients can receive timely follow-up and care. Dr. Jennifer Dillaha, Arkansas Department of Health State Epidemiologist and Medical Director of Immunizations and Outbreak Response, has shared a presentation with APA to help inform pharmacists about using the ADH portal for reporting COVID-19 test results. Click here to download the presentation.
- In order to administer the COVID-19 vaccination to patients 18 years of age or younger, pharmacists must inform the patient and the adult caregiver of the importance of a well-child visit with a pediatrician or other licensed primary-care provider and refer patients as appropriate. A Task Force on Pharmacist Engagement in State-Based COVID Vaccination has developed three tools for use by pharmacists to satisfy this requirement:
- CDC Redistribution Agreement
- APA & ADH Hub & Spoke Agreement
Patient Information
|
